Pharvaris N.V. 9EN.F Stock
Pharvaris N.V. Price Chart
Pharvaris N.V. 9EN.F Financial and Trading Overview
| Pharvaris N.V. stock price | 18.2 EUR |
| Previous Close | 10.2 EUR |
| Open | 10 EUR |
| Bid | 10.1 EUR x N/A |
| Ask | 10.5 EUR x N/A |
| Day's Range | 10 - 10 EUR |
| 52 Week Range | 1.87 - 25.8 EUR |
| Volume | 1.03K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 351.21M EUR |
| Beta (5Y Monthly) | -4.583832 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.48 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 43.14 EUR |
9EN.F Valuation Measures
| Enterprise Value | 203.52M EUR |
| Trailing P/E | N/A |
| Forward P/E | -3.4246573 |
| PEG Ratio (5 yr expected) | -0.68 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.6198585 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.302 |
Trading Information
Pharvaris N.V. Stock Price History
| Beta (5Y Monthly) | -4.583832 |
| 52-Week Change | -50.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 25.8 EUR |
| 52 Week Low | 1.87 EUR |
| 50-Day Moving Average | 7.83 EUR |
| 200-Day Moving Average | 7.16 EUR |
9EN.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 33.83M |
| Float | 12.58M |
| Short Ratio | N/A |
| % Held by Insiders | 9.62% |
| % Held by Institutions | 73.73% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -31.67% |
| Return on Equity (ttm) | -51.82% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -88391784 EUR |
| Net Income Avi to Common (ttm) | -82936480 EUR |
| Diluted EPS (ttm) | -2.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 135.18M EUR |
| Total Cash Per Share (mrq) | 4 EUR |
| Total Debt (mrq) | 386.52K EUR |
| Total Debt/Equity (mrq) | 0.3 EUR |
| Current Ratio (mrq) | 7.955 |
| Book Value Per Share (mrq) | 3.817 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -74486224 EUR |
| Levered Free Cash Flow (ttm) | -40899176 EUR |
Profile of Pharvaris N.V.
| Country | Germany |
| State | N/A |
| City | Leiden |
| Address | Emmy Noetherweg 2 |
| ZIP | 2333 CH |
| Phone | 31 71 203 6410 |
| Website | https://pharvaris.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 66 |
Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands.
Q&A For Pharvaris N.V. Stock
What is a current 9EN.F stock price?
Pharvaris N.V. 9EN.F stock price today per share is 18.2 EUR.
How to purchase Pharvaris N.V. stock?
You can buy 9EN.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharvaris N.V.?
The stock symbol or ticker of Pharvaris N.V. is 9EN.F.
Which industry does the Pharvaris N.V. company belong to?
The Pharvaris N.V. industry is Biotechnology.
How many shares does Pharvaris N.V. have in circulation?
The max supply of Pharvaris N.V. shares is 54.39M.
What is Pharvaris N.V. Price to Earnings Ratio (PE Ratio)?
Pharvaris N.V. PE Ratio is now.
What was Pharvaris N.V. earnings per share over the trailing 12 months (TTM)?
Pharvaris N.V. EPS is -2.48 EUR over the trailing 12 months.
Which sector does the Pharvaris N.V. company belong to?
The Pharvaris N.V. sector is Healthcare.